GA has the ability to inhibit cardiac fibrosis triggered by isoproterenol (ISO) via inhibiting the HMGB1/TLR2 signaling pathway, similar to its effect on liver fibrosis(Wu et al. 2018). The gene discussed is HMGB1; the disease is Hepatic fibrosis.